JPH0254327B2 - - Google Patents

Info

Publication number
JPH0254327B2
JPH0254327B2 JP56194887A JP19488781A JPH0254327B2 JP H0254327 B2 JPH0254327 B2 JP H0254327B2 JP 56194887 A JP56194887 A JP 56194887A JP 19488781 A JP19488781 A JP 19488781A JP H0254327 B2 JPH0254327 B2 JP H0254327B2
Authority
JP
Japan
Prior art keywords
hydrochloride
red blood
sickle cell
therapeutic agent
cell anemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56194887A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5896019A (ja
Inventor
Akira Hayashi
Koichi Kidoguchi
Tomio Fujita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Priority to JP56194887A priority Critical patent/JPS5896019A/ja
Publication of JPS5896019A publication Critical patent/JPS5896019A/ja
Publication of JPH0254327B2 publication Critical patent/JPH0254327B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56194887A 1981-12-03 1981-12-03 鎌型赤血球貧血症治療剤 Granted JPS5896019A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56194887A JPS5896019A (ja) 1981-12-03 1981-12-03 鎌型赤血球貧血症治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56194887A JPS5896019A (ja) 1981-12-03 1981-12-03 鎌型赤血球貧血症治療剤

Publications (2)

Publication Number Publication Date
JPS5896019A JPS5896019A (ja) 1983-06-07
JPH0254327B2 true JPH0254327B2 (enExample) 1990-11-21

Family

ID=16331971

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56194887A Granted JPS5896019A (ja) 1981-12-03 1981-12-03 鎌型赤血球貧血症治療剤

Country Status (1)

Country Link
JP (1) JPS5896019A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7620782B2 (en) 2003-05-09 2009-11-17 Lg Electronics Inc. Recording medium having data structure for managing at least a data area of the recording medium and recording and reproducing methods and apparatuses

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2008044337A1 (ja) 2006-10-13 2010-02-04 興和株式会社 γ−グロビン誘導剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7620782B2 (en) 2003-05-09 2009-11-17 Lg Electronics Inc. Recording medium having data structure for managing at least a data area of the recording medium and recording and reproducing methods and apparatuses

Also Published As

Publication number Publication date
JPS5896019A (ja) 1983-06-07

Similar Documents

Publication Publication Date Title
JP2002502869A (ja) メトホルミンおよびフィブラートとの組み合わせからなる医薬組成物と、高血糖症を緩和するための医薬品製造へのその使用
JPH10509143A (ja) ２，２′−ジチオ−ビス（エタンスルホネート）（ジメスナ）と組み合わせたシスプラチン組成物
EP0349235A2 (en) Niacin and guar-gum containing composition
AU610134B2 (en) Use of metformin in the preparation of medicines
TW201429473A (zh) 腫瘤溶解症候群之治療劑及預防劑
CN1313856A (zh) 噻唑啉酸衍生物
US20210228490A1 (en) Stable pharmaceutical formulation
JP2002537258A5 (enExample)
JPS61151123A (ja) 安定化された３―オキシゲルミルプロピオン酸ポリマーを有効成分とする免疫調整剤
US6720011B1 (en) Injectable composition for cancer treatment
JP2018501291A (ja) スルホンアミド系医薬組成物
CN105246483A (zh) 用于γ-谷氨酰循环调节的方法和组合物
JPH0254327B2 (enExample)
AU782838B2 (en) Solution of N-(O-(p-pivaloyloxy benzene sulfonylamino) benzoyl)glycine monosodium salt tetra-hydrate and drug product thereof
JP2021505531A (ja) 医薬組成物
CN114569545B (zh) 一种稳定的米托蒽醌制剂
BG64766B1 (bg) Стабилни състави, съдържащи левосимендан и алгинова киселина
CA2566684C (en) Pharmaceutical nitrones
JPH03157385A (ja) 細胞防護剤
JPH08165236A (ja) 下痢の予防及び治療剤
JP2727343B2 (ja) サラセミア症治療剤
JPH072674A (ja) 白血病治療剤
JPH09323934A (ja) 保存安定性の改善された坐剤
US20170028013A1 (en) Combination formulation of laquinimod and glatiramer acetate with amino acids
WO2024263856A1 (en) Oral formulations comprising avatrombopag and related uses